Clinical research conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) continues to ...

BioMark Strengthens Liquid Biopsy Platform for Breast Cancer Detection Vancouver, British Columbia--( - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), ...

Researchers provided recommendations for managing adverse events in patients with renal cell carcinoma receiving cabozantinib and nivolumab.

Cellectis presents several strategies using TALEN®-mediated gene editing to generate allogeneic CAR T-cells while repurposing PD-1 function with tightly regulated functionalities, with the objective ...

Turnstone Biologics (TSBX) announced it will be presenting two posters highlighting preclinical data on methods for TIL selection at the ...

ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.

Many many many executions are warranted,” one Trump supporter wrote on Truth Social. “These traitors are a terminal cancer ...

"We are pleased with our operational and clinical execution this quarter and look forward to sharing additional clinical data ...

SAN FRANCISCO and CHICAGO, Nov. 7, 2024 /PRNewswire/ -- cTRL Therapeutics, a biotechnology company advancing next-generation ce ...

In the first study, titled "The Anti-tumor Response of BPM31510 is Associated with Immune Cell Regulation in the Tumor Microenvironment," researchers showed that BPM31510 significantly increases ...

Six studies highlight advancements in AI-powered tumor microenvironment profiling, genomic analysis, biomarker identification, immune-related adverse ...